Wednesday, August 5, 2026

6,000 More North Koreans Headed to Russia? Seoul Says It’s Illegal

South Korea warns against North Korea's plan to send 6,000 workers to Russia, citing violations of UN resolutions and urging compliance with international law.

SEVENTEEN’s Joshua Returns to UNESCO: What to Expect from the Youth Celebration Event

Joshua from SEVENTEEN will attend a UNESCO event in Paris as a Youth Ambassador, promoting youth creativity and well-being.

BIO USA 2025: Korea’s Pavilion Grows, Deals Multiply, and New Biotech Faces Emerge

BIO USA 2025 showcased South Korea's biotech presence, with significant participation from firms like Samsung Biologics and Lotte Biologics.

Health

5 Key Research Findings on Dr. Noon CVD: A Game-Changer for Cardiovascular Disease Prevention

Mediwhale presented five abstracts on its AI-based cardiovascular risk assessment solution, Dr. Noon CVD, at the ASPC conference.

“Improved Survival Rates”… Carboplatin Combination Therapy Shows Benefit in Triple-Negative Breast Cancer

Adding carboplatin to chemotherapy for operable triple-negative breast cancer reduces recurrence risk and improves survival, study finds.

Inventage Lab Selected for Global TIPS Program, Accelerating Late-Stage Development of Addiction Treatment

Inventis Lab's long-acting drug IVL3004 for addiction treatment has been selected for the Global TIPS research project by the Ministry of SMEs.

Bukwang Pharm Signs Export Agreement With Thailand’s Pacific Healthcare for Dexid

Bukwang Pharmaceutical signs exclusive export contract for diabetes treatment 'Dexide' with Pacific Healthcare in Thailand.

Huawei Unveils OpenPangu 2.0 Pro: Is This the Future of AI with 505 Billion Parameters?

Huawei accelerates its AI ecosystem expansion by revealing the source of its massive AI model with over 500 billion parameters.
Latest

JLK’s Stroke AI Goes Subscription-Based as University Hospitals Drive Adoption

JLK's stroke AI solution enhances diagnosis and treatment at Chung-Ang University Hospital, improving patient care and revenue growth.

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

Weight-Loss Drugs Could Cut Airline Fuel Bills by $580 Million—An Unexpected Win for U.S. Carriers

The obesity treatment market is growing, helping U.S. airlines save on fuel costs due to decreased passenger weight.

Does Tylenol Raise Autism Risk? What a Review of 43 Studies and 1 Million Children Shows

A European study confirms Tylenol's safety during pregnancy, countering claims linking it to autism, ADHD, and intellectual disabilities.

Novo Nordisk’s Wegovy Pill Draws 3,000 Prescriptions in Its First Week—Is Oral GLP-1 Here to Stay?

Novo Nordisk's Wegovy oral obesity treatment saw over 3,000 prescriptions in its first week, indicating strong market demand.

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Unlocking the Secrets of Hugel’s 900 Million USD Revenue Goal: A Comprehensive Guide

Hugel aims for 900 billion KRW in U.S. sales by 2028, leveraging a hybrid sales model to capture significant market share.

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

K-Bio Revolution: How Korean Biopharmaceuticals Are Conquering the Global Market in 2026

South Korea's pharmaceutical industry thrives with innovative drugs like botulinum toxins and cancer treatments, targeting global markets.

Nvidia and Eli Lilly: How AI is Revolutionizing Drug Development in 2026

Nvidia partners with Eli Lilly to enhance AI in drug development, aiming to revolutionize the biotech industry.

How Celltrion Plans to Expand Its Biosimilar Portfolio to 41 Products by 2038

Celltrion unveils its growth strategy at the JP Morgan Healthcare Conference, aiming to expand biosimilars and develop new drug pipelines.

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.